A Phase 1, Open-label, Single-Dose Study to Investigate the Pharmacokinetics of DSP-6952 in Healthy Elderly and Young Males and Females
Phase 1
Completed
- Conditions
- Healthy Elderly and Young Males and Females
- Registration Number
- JPRN-jRCT2080225002
- Lead Sponsor
- Sumitomo Dainippon Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Healthy males and females who are aged >= 65 and < 80 years in case of elderly subjects or >= 20 and < 40 years in case of young subjects at informed consent etc.
Exclusion Criteria
Subjects with a history of any significant disease such as cardiovascular, hepatic, renal, endocrine, gastrointestinal, hematological, respiratory, central nervous system or psychoneurological disease that is inappropriate for participation in this study in the opinion of the Investigator etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pharmacokinetics<br>DSP-6952 pharmacokinetic parameters
- Secondary Outcome Measures
Name Time Method safety<br>Adverse events, adverse drug reactions, laboratory tests, vital signs, and 12-lead electrocardiography